PROM1 and ovarian cancer: Indeed, an increase in endothelin A receptor (ETAR) expression has been observed in CD133+ ovarian cancer stem-like cells and primary cultures, and sphere formation was reduced by using receptor antagonists in combination with chemotherapy [48].